Abstract
Early detection of prostate cancer with PSA screening and transrectal ultrasound-guided prostate biopsy has led to stage migration and decreased prostate cancer-related death. Early experience with laterally directed sextant prostate biopsy demonstrated good yield for early prostate cancer detection, but at a cost of missing some smaller cancers. Extended (12–14 cores) prostate biopsies enhanced this yield, and with the development of effective local prostatic nerve block techniques, office-based saturation biopsy techniques with 20 or more cores have become the gold standard for prostate cancer detection in patients with high risk features, although intriguing data on transperineal template-guided mapping biopsy are emerging. Improved detection of small cancers assists the patient and clinician in making treatment decisions, including the decision to embark on active surveillance of a small low grade prostate cancer. In the setting of detecting a small high grade cancer, early detection can potentially improve overall survival rates.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carroll PR. Early stage prostate cancer – do we have a problem with over-detection, overtreatment or both? J Urol. 2005;173(4):1061–2.
Hodge KK, McNeal JE, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142(1):71–4 (discussion 74–5).
Stamey TA. Making the most out of six systematic sextant biopsies. Urology. 1995;45(1):2–12.
Lui PD, Terris MK, et al. Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol. 1995;153(3 Pt 2):1000–3.
Gore JL, Shariat SF, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 2001;165(5): 1554–9.
Epstein JI, Walsh PC, et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271(5):368–74.
Patel MI, DeConcini DT, et al. An analysis of men with clinically localized prostate cancer who deferred definitive therapy. J Urol. 2004;171(4):1520–4.
Tosoian JJ, Trock BJ, et al. Active surveillance program for prostate cancer: An update of the johns Hopkins experience. J Clin Oncol. 2011;29(16): 2185–90.
Klotz L, Zhang L, et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28(1): 126–31.
Tan N, Lane BR, et al. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. J Urol. 2008;180(4):1325–9 (discussion 1329).
Berglund RK, Masterson TA, et al. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J Urol. 2008;180(5):1964–7 (discussion 1967–8).
Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol. 1994;151(6): 1571–4.
Roehl KA, Antenor JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol. 2002;167(6):2435–9.
Borboroglu PG, Comer SW, et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 2000;163(1):158–62.
Soloway MS, Obek C. Periprostatic local anesthesia before ultrasound guided prostate biopsy. J Urol. 2000;163(1):172–3.
Jones JS, Ulchaker JC, et al. Periprostatic local anesthesia eliminates pain of office-based transrectal prostate biopsy. Prostate Cancer Prostatic Dis. 2003;6(1): 53–5.
Patel AR, Jones JS, et al. Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology. 2004;63(1):87–9.
Ching CB, Zaytoun O, Moussa AS, Li J, Avallone A, Jones JS. Type of transrectal ultrasonography probe influences prostate cancer detection rates on repeat prostate biopsy. BJU Int. 2012;110(2 Pt B):E46–9.
Ching CB, Moussa AS, et al. Does transrectal ultrasound probe configuration really matter? End fire versus side fire probe prostate cancer detection rates. J Urol. 2009;181(5):2077–82 (discussion 2082–3).
Zaytoun OM, Moussa AS, et al. Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. J Urol. 2011;186(3):850–4.
Abouassaly R, Lane BR, Jones JS. Staging saturation biopsy in patients with prostate cancer on active surveillance protocol. Urology. 2008;71(4):573–7.
Emiliozzi P, Corsetti A, et al. Best approach for prostate cancer detection: A prospective study on transperineal versus transrectal six-core prostate biopsy. Urology. 2003;61(5):961–6.
Watanabe M, Hayashi T, et al. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int J Urol. 2005;12(11):959–63.
Abdollah F, Novara G, et al. Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: Is there a difference in cancer detection rate? Urology. 2011;77(4):921–5.
Barzell WE, Melamed MR. Appropriate patient selection in the focal treatment of prostate cancer: The role of transperineal 3-dimensional pathologic mapping of the prostate–a 4-year experience. Urology. 2007;70(6 Suppl):27–35.
Onik G, Miessau M, Bostwick DG. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol. 2009;27(26):4321–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Berglund, R., Jones, J.S. (2013). Biopsy Strategies to Detect Small Prostate Cancers. In: Polascik, T. (eds) Imaging and Focal Therapy of Early Prostate Cancer. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-182-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-62703-182-0_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-181-3
Online ISBN: 978-1-62703-182-0
eBook Packages: MedicineMedicine (R0)